(Q46666219)

24 December 2017

title

Population characteristics of hepatic dihydropyrimidine dehydrogenase activity, a key metabolic enzyme in 5-fluorouracil chemotherapy (English)

1 reference

24 December 2017

Population characteristics of hepatic dihydropyrimidine dehydrogenase activity, a key metabolic enzyme in 5-fluorouracil chemotherapy* (English)

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

26 May 2024

1 reference

1 reference

Z. Lu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586945

26 May 2024

R. Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586945

26 May 2024

R. B. Diasio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586945

26 May 2024

language of work or name

English

0 references

publication date

1 November 1995

1 reference

24 December 2017

Clinical Pharmacology & Therapeutics

published in

1 reference

24 December 2017

volume

58

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

page(s)

512-522

1 reference

24 December 2017

Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases

cites work

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990171-X

Clinical pharmacology of 5-fluorouracil

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

Comparison of dihydropyrimidine dehydrogenase from human, rat, pig and cow liver. Biochemical and immunological properties

26 May 2024

5

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

Circadian rhythm of rat liver dihydropyrimidine dehydrogenase. Possible relevance to fluoropyrimidine chemotherapy

26 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer

26 May 2024

11

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

Familial pyrimidinemia and pyrimidinuria associated with severe fluorouracil toxicity

26 May 2024

12

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity

26 May 2024

13

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome

26 May 2024

14

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

Severe 5-fluorouracil toxicity in a patient with decreased dihydropyrimidine dehydrogenase activity

26 May 2024

15

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

Severe fluorouracil toxicity in a patient with dihydropyrimidine dehydrogenase deficiency

26 May 2024

17

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

Population study of dihydropyrimidine dehydrogenase in cancer patients

26 May 2024

20

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

Influence of sex and age on fluorouracil clearance

26 May 2024

21

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

26 May 2024

25

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

26 May 2024

26

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

Progress in liver diseases

26 May 2024

27

9

307

Meyer U. A.

1990

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

European Journal of Cancer

26 May 2024

28

29A

740

Fleming R. A.

1993

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

Proceedings of the American Association for Cancer Research

26 May 2024

29

35

227

Lu Z.

1994

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

Proceedings of the American Association for Cancer Research

26 May 2024

30

35

200

Zhang R.

1994

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90171-X

26 May 2024

Identifiers

1 reference

24 December 2017

1 reference

24 December 2017